Integrating and adopting mathematical models and digital twins into clinical decision-making

References

[1] National Academies of Sciences, Engineering, Medicine. Opportunities and challenges for digital twins in biomedical research: proceedings of a workshop–in brief. The National Academies Press; 2023.

[2] Yankeelov TE, Hormuth DA , Lima EABF, et al. Designing clinical trials for patients who are not average. iScience. 2024;27:108589.

[3] Zahid MU, Mohsin N, Mohamed AS, et al. Forecasting individual patient response to radiation therapy in head and neck cancer with a dynamic carrying capacity model. Int J Radiat Oncol Biol Phys. 2021;111:693-704.

[4] Ferrari A, Willcox K. Digital twins in mechanical and aerospace engineering. Nat Comput Sci. 2024;4:178-183.

[5] Brady R, Enderling H. Mathematical models of cancer: when to predict novel therapies, and when not to. Bull Math Biol. 2019;81:3722-3731.

[6] Pasetto S, Gatenby R, Enderling H. Bayesian framework to augment tumour board decision making. JCO Clin Cancer Inform. 2021;5:508-517.

[7] Prokopiou S, Moros EG, Poleszczuk J, et al. A proliferation saturation index to predict radiation response and personalise radiotherapy fractionation. Radiat Oncol. 2015;10:159.

[8] Caudell JJ, Echevarria M, Yang G, et al. Phase II prospective trial of personalised radiotherapy fractionation in human papillomavirus positive oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2026.

[9] Robertson-Tessi M, Brown JS, Poole MI, et al. Feasibility of an evolutionary tumour board for generating novel personalised therapeutic strategies. medRxiv. 2023;18:23284628.

[10] Glazar DJ, Grass GD, Arrington JA, et al. Tumour volume dynamics as an early biomarker for patient-specific evolution of resistance and progression in recurrent high-grade glioma. J Clin Med. 2020;9(7):2019.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.